Sara Toffanin - Concepedia

Author

Sara Toffanin

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Also Known As

Llovet, Josep M., Sara Toffanin, Toffanin Sara

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Institució Catalana de Recerca i Estudis Avançats Icahn School of Medicine at Mount Sinai Broad Institute Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

About

Sara Toffanin is an author at Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas specializing in medicine, hepatocellular carcinoma, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.3K
2	Cell Biology	3	3	1.2K
3	Engineering	2	2	172
4	Health Sciences	2	2	273
5	Natural Sciences	1	1	100

Sara Toffanin

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Lin28 promotes transformation and is associated with advanced human malignancies Srinivas R. Viswanathan, John T. Powers, William S. Einhorn, Nature Genetics Tumor BiologyOncologyOncogenic AgentMedicinePathology	2009	814
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma Augusto Villanueva, Derek Y. Chiang, Pippa Newell, Gastroenterology	2008	722
Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice Augusto Villanueva, Clara Alsinet, Kilangsungla Yanger, Gastroenterology Tumor BiologyInduces Tumor FormationSignaling PathwayHepatologyHuman Hepatocellular Carcinoma	2012	311
Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib Anja Lachenmayer, Clara Alsinet, Radoslav Savić, Clinical Cancer Research	2012	296
MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a Sara Toffanin, Yujin Hoshida, Anja Lachenmayer, Gastroenterology	2011	232
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage Victoria Tovar, Clara Alsinet, Augusto Villanueva, Journal of Hepatology HepatologyIgf-1r BlockageLiver PhysiologyPathologyLiver Cancer	2010	220
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo Pippa Newell, Sara Toffanin, Augusto Villanueva, Journal of Hepatology Hepatocellular CarcinomaMedicineAnti-tumoral EffectRas Pathway ActivationPathology	2009	219
Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib Anja Lachenmayer, Sara Toffanin, Laia Cabellos, Journal of Hepatology HepatologyMedicinePharmacologyHdac Inhibitor PanobinostatCombination Therapy	2012	200
Gene-expression signature of vascular invasion in hepatocellular carcinoma Beatriz Mínguez, Yujin Hoshida, Augusto Villanueva, Journal of Hepatology HepatologyHepatocellular CarcinomaVascular InvasionPathologyLiver Cancer	2011	169
New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers Augusto Villanueva, Yujin Hoshida, Sara Toffanin, Clinical Cancer Research Accurate Prognosis PredictionEngineeringPathologyPatient PrognosisTumor Biology	2010	122

Page 1